Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
1(10%)
Results Posted
40%(2 trials)
Terminated
1(10%)

Phase Distribution

Ph phase_1
1
10%
Ph not_applicable
3
30%
Ph phase_2
1
10%
Ph phase_3
1
10%

Phase Distribution

1

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 2Efficacy & side effects
1(16.7%)
Phase 3Large-scale testing
1(16.7%)
N/ANon-phased studies
3(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(1)
Completed(5)
Terminated(1)
Other(3)

Detailed Status

Completed5
unknown3
Active, not recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
1
Success Rate
83.3%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (16.7%)
Phase 21 (16.7%)
Phase 31 (16.7%)
N/A3 (50.0%)

Trials by Status

unknown330%
active_not_recruiting110%
completed550%
terminated110%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
10